Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
79.99
-10.45 (-11.55%)
At close: Dec 5, 2025, 4:00 PM EST
80.02
+0.03 (0.04%)
After-hours: Dec 5, 2025, 7:43 PM EST
Spruce Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 10.67 | 38.75 | 96.34 | 24.49 | 42.75 | 157.15 | Upgrade
|
| Short-Term Investments | - | - | - | 54.59 | 46.22 | - | Upgrade
|
| Cash & Short-Term Investments | 10.67 | 38.75 | 96.34 | 79.08 | 88.97 | 157.15 | Upgrade
|
| Cash Growth | -82.23% | -59.77% | 21.83% | -11.12% | -43.39% | 3904.84% | Upgrade
|
| Prepaid Expenses | 0.93 | 3.18 | 3.88 | 3.32 | 2.53 | 2.97 | Upgrade
|
| Restricted Cash | - | - | - | 0.22 | - | - | Upgrade
|
| Other Current Assets | 2.92 | 2.28 | 1.97 | 1 | 0.4 | 0.28 | Upgrade
|
| Total Current Assets | 14.52 | 44.21 | 102.18 | 83.61 | 91.9 | 160.4 | Upgrade
|
| Property, Plant & Equipment | 0.74 | 0.93 | 1.18 | 1.4 | 1.48 | 1.87 | Upgrade
|
| Long-Term Investments | - | - | - | - | 32.46 | - | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.07 | 0.58 | 0.64 | 0.65 | 0.62 | Upgrade
|
| Total Assets | 15.31 | 45.21 | 103.95 | 85.65 | 126.49 | 162.88 | Upgrade
|
| Accounts Payable | 1.39 | 1.3 | 3.33 | 1.43 | 2.82 | 3.63 | Upgrade
|
| Accrued Expenses | 6.96 | 12.05 | 14.35 | 9.26 | 5.69 | 3.33 | Upgrade
|
| Current Portion of Long-Term Debt | 0.54 | 1.62 | 1.62 | 1.62 | - | 2.55 | Upgrade
|
| Current Portion of Leases | 0.31 | 0.28 | 0.25 | 0.14 | 0.36 | 0.25 | Upgrade
|
| Current Unearned Revenue | - | - | 4.91 | - | - | - | Upgrade
|
| Total Current Liabilities | 9.43 | 15.25 | 24.47 | 12.45 | 8.87 | 9.76 | Upgrade
|
| Long-Term Debt | - | 0.12 | 1.72 | 3.29 | 4.88 | 1.92 | Upgrade
|
| Long-Term Leases | 0.5 | 0.74 | 1.02 | 1.26 | 1.29 | 1.65 | Upgrade
|
| Other Long-Term Liabilities | - | 0.28 | 0.24 | 0.16 | 0.07 | 0.12 | Upgrade
|
| Total Liabilities | 9.93 | 16.39 | 27.44 | 17.16 | 15.12 | 13.46 | Upgrade
|
| Common Stock | - | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 279.97 | 279.09 | 273.74 | 218.35 | 214.69 | 210.27 | Upgrade
|
| Retained Earnings | -274.59 | -250.27 | -197.23 | -149.31 | -103.13 | -60.84 | Upgrade
|
| Comprehensive Income & Other | - | - | - | -0.56 | -0.18 | - | Upgrade
|
| Total Common Equity | 5.39 | 28.82 | 76.51 | 68.49 | 111.37 | 149.43 | Upgrade
|
| Shareholders' Equity | 5.39 | 28.82 | 76.51 | 68.49 | 111.37 | 149.43 | Upgrade
|
| Total Liabilities & Equity | 15.31 | 45.21 | 103.95 | 85.65 | 126.49 | 162.88 | Upgrade
|
| Total Debt | 1.35 | 2.77 | 4.61 | 6.32 | 6.53 | 6.38 | Upgrade
|
| Net Cash (Debt) | 9.32 | 35.99 | 91.73 | 72.76 | 82.44 | 150.77 | Upgrade
|
| Net Cash Growth | -83.60% | -60.77% | 26.07% | -11.74% | -45.32% | - | Upgrade
|
| Net Cash Per Share | 16.06 | 65.41 | 178.65 | 231.95 | 264.66 | 1887.41 | Upgrade
|
| Filing Date Shares Outstanding | 1.07 | 0.56 | 0.55 | 0.53 | 0.31 | 0.31 | Upgrade
|
| Total Common Shares Outstanding | 0.56 | 0.56 | 0.55 | 0.31 | 0.31 | 0.31 | Upgrade
|
| Working Capital | 5.09 | 28.96 | 77.72 | 71.16 | 83.02 | 150.63 | Upgrade
|
| Book Value Per Share | 9.56 | 51.18 | 139.85 | 217.64 | 355.56 | 481.81 | Upgrade
|
| Tangible Book Value | 5.39 | 28.82 | 76.51 | 68.49 | 111.37 | 149.43 | Upgrade
|
| Tangible Book Value Per Share | 9.56 | 51.18 | 139.85 | 217.64 | 355.56 | 481.81 | Upgrade
|
| Machinery | - | - | - | - | - | 0.06 | Upgrade
|
| Leasehold Improvements | - | - | - | - | - | 0.01 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.